| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.002 | 35.384 | 43.526 | 36.832 | 35.484 | 22.643 | 36.185 | 46.490 | 65.065 | 80.893 |
| Total Income - EUR | 27.002 | 35.385 | 43.526 | 36.832 | 35.484 | 22.643 | 36.185 | 46.490 | 65.065 | 86.573 |
| Total Expenses - EUR | 25.395 | 23.835 | 24.044 | 23.686 | 15.317 | 13.413 | 19.588 | 36.617 | 41.555 | 45.067 |
| Gross Profit/Loss - EUR | 1.607 | 11.549 | 19.482 | 13.146 | 20.168 | 9.229 | 16.597 | 9.873 | 23.510 | 41.507 |
| Net Profit/Loss - EUR | 797 | 10.841 | 19.047 | 12.777 | 19.812 | 8.979 | 16.160 | 9.408 | 22.859 | 38.909 |
| Employees | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Acta Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 3.783 | 2.479 | 1.216 | 10.824 | 7.902 | 4.829 | 1.938 | 0 | 0 |
| Current Assets | 3.551 | 10.179 | 18.104 | 13.028 | 22.699 | 33.962 | 52.902 | 65.437 | 90.241 | 128.941 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 22 | 0 | 0 | 0 | 0 |
| Receivables | 4 | 4 | 0 | 1.058 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Cash | 3.547 | 10.175 | 18.104 | 11.970 | 21.645 | 32.906 | 51.891 | 64.423 | 14.429 | 13.012 |
| Shareholders Funds | 1.712 | 12.536 | 19.112 | 12.843 | 32.407 | 40.772 | 56.028 | 65.610 | 88.270 | 126.686 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.839 | 1.426 | 1.471 | 1.401 | 1.116 | 1.092 | 1.703 | 1.765 | 1.971 | 2.255 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Acta Med Srl